UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of of Report (Date of earliest event reported): May ~~December 23~~6, ~~2025~~2026

AMERICAN CANNABIS COMPANY, INC.

(Exact Name of Registrant as Specified in its Charter)

Delaware

(State or other jurisdiction of incorporation or organization)

Commission File Number

000-26108

90-1116625

(I.R.S. Employer

Identification Number)

1004 S Tejon St Colorado Springs, CO 80903

(Address of Principal Executive Offices and Zip Code)

(303) 974-4770

(Issuer's telephone number)

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class	Trading Symbols	Name of Exchange on Which Registered
Common	AMMJ	None

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company [ ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]

Item 5.02 —– Departure of Directors or Certain Officers; ~~Appointment~~ Election of ~~Certain Officers~~Directors; ~~Compensatory~~Appointment ~~Arrangements~~ of Certain Officers.

On ~~December 23, 2025, Ellis Smith resigned from his~~ ~~positions as Chief Executive Officer~~May 6, ~~Chief Financial Officer, and Chairman of~~ the Board of Directors of ~~American~~AMMJ ~~Cannabis Company~~ (the “Company”), effective immediately. Mr. Smith’s resignation was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies, or practices. On the same date, the Board of Directors appointed ~~Joe~~Griffin ~~Cleghorn~~Brahms ~~as Interim Chief Executive Officer of the Company, effective immediately. Additionally, on December 23, 2025, the Board of Directors appointed James Woodend~~ to serve as a member of the Company’s Board of Directors ~~of the Company~~, effective immediately. There are no arrangements or understandings between Mr. Cleghorn or Mr. Woodend and any other person pursuant to which they were selected for their respective positions, other than standard corporate governance considerations.

~~Item~~Mr. Brahms 9is a cannabis industry professional with nearly a decade of experience in account management, business development, and client relations within the regulated cannabis market.01 —Since ~~Financial~~2018, ~~Statements~~he has served as an Account Manager at Harmony Extracts in Colorado, where he has focused on retail partnerships, operational growth, and ~~Exhibits~~strategic business relationships.

~~(d)~~Prior to ~~Exhibits~~his work in the cannabis industry, Mr. Brahms worked in digital content and market research in New York City, developing experience in consumer behavior, brand strategy, and audience engagement.

None.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: December 23, 2025

AMERICAN CANNABIS COMPANY, INC.

(Registrant)

By: /s/ James ~~Joe Cleghorn~~Woodend

~~Joe~~Name: James ~~Cleghorn~~Woodend

~~Interim~~Date: May ~~Chief~~11, ~~Executive Officer~~2026

Title: CEO

Filing Compare · American Cannabis Company, Inc.